Elan Sells Back Frova Rights; Vernalis Plans Menstrual Migraine Filing In 2005
Vernalis is seeking a new U.S. marketing partner for the triptan. Elan will use proceeds from the $55 mil. deal toward the Antegren launch.
Vernalis is seeking a new U.S. marketing partner for the triptan. Elan will use proceeds from the $55 mil. deal toward the Antegren launch.